Supernus Pharmaceuticals (SUPN) Revenue (2011 - 2026)
Supernus Pharmaceuticals (SUPN) posted quarterly Revenue of $219.1 million for Q2 2026, up 32.4% year-over-year from $165.5 million in Q2 2025, and up 3.54% on a QoQ basis from $211.6 million in Q4 2025.
Supernus Pharmaceuticals (SUPN) Revenue (2011 - 2026) Analysis & Trends
Supernus Pharmaceuticals has reported Revenue for 16 years, with the latest figure at $219.1 million in Q2 2026.
- Revenue for Q2 2026 came in at $219.1 million, up 32.4% year-over-year; the trailing twelve-month figure through Jun 2026 was $788.2 million (up 18.5% YoY), and the FY2025 annual result was $719.0 million, up 8.63% from the prior year.
- Revenue improved to $219.1 million in Q2 2026, from $211.6 million in the prior quarter.
- Over five years, Revenue peaked at $219.1 million in Q2 2026 and troughed at $135.6 million in Q2 2023.
- A 5-year average of $169.1 million and a median of $167.3 million in 2022 frame the typical range for Revenue.
- The widest annual swing landed in 2023, when Revenue slipped 20.28%; it then surged 32.4% in 2026.
- A 5-year view of Revenue shows it stood at $167.3 million in 2022, then fell by 1.8% to $164.3 million in 2023, then advanced by 5.99% to $174.2 million in 2024, then gained by 21.48% to $211.6 million in 2025, then gained by 3.54% to $219.1 million in 2026.
- Per Business Quant data, the three most recent Revenue figures were $219.1 million in Q2 2026, $211.6 million in Q4 2025, and $192.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | 4.14 Bn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 2.47 Bn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 7.65 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 783.30 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | 3.76 Bn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 959.00 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 1.37 Bn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Supernus Pharmaceuticals | 2.78 Bn | 2.41 Bn | 185.39 Mn | 219.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 219.06 Mn |
| Dec 31, 2025 | 211.57 Mn |
| Sep 30, 2025 | 192.10 Mn |
| Jun 30, 2025 | 165.45 Mn |
| Mar 31, 2025 | 149.82 Mn |
| Dec 31, 2024 | 174.16 Mn |
| Sep 30, 2024 | 175.69 Mn |
| Jun 30, 2024 | 168.33 Mn |
| Mar 31, 2024 | 143.64 Mn |
| Dec 31, 2023 | 164.31 Mn |
| Sep 30, 2023 | 153.88 Mn |
| Jun 30, 2023 | 135.56 Mn |
| Mar 31, 2023 | 153.76 Mn |
| Dec 31, 2022 | 167.33 Mn |
| Sep 30, 2022 | 177.35 Mn |
| Jun 30, 2022 | 170.05 Mn |
| Mar 31, 2022 | 152.51 Mn |
| Dec 31, 2021 | 159.05 Mn |
| Sep 30, 2021 | 148.46 Mn |
| Jun 30, 2021 | 141.33 Mn |